Articles Posted in Product Liability

As a Dallas Personal Injury and Product Liability Attorney, we are providing this timely news regarding the alleged uterus perforation injuries from the use of a commonly prescribed birth control device known as an Intra Uterine Device (IUD), the Mirena IUD.

Bayer, the manufacturer of Mirena IUD, pushed to centralize its product liability and personal injury lawsuits into New Jersey State Court. The lawsuits are brought by women who experienced serious and often debilitating injuries from the implanted birth control device. Upon review the Supreme Court of New Jersey has decided not to consolidate all Mirena IUD lawsuits.

Now each case filed throughout New Jersey will continue to be litigated individually. Bayer Healthcare filed a request to centralize the New Jersey Mirena litigation in its home state, the company headquarters.

As a Dallas Personal Injury and Product Liability Attorney, we are providing this timely news regarding the alleged Fresenius Granuflo and Naturalyte serious and catastrophic injuries during dialysis. Fresenius Medical Care has agreed to multidistrict litigation (MDL) consolidation for all federal NaturaLyte and Granuflo lawsuits. The injured plaintiffs allege that the dialysis products manufactured, distributed and used by Fresenius Medical Care during dialysis caused patients to suffer a cardiac arrest, heart attack or sudden death.

Many injured kidney failure patients have filed claims against Fresenius Granuflo and Naturalyte, alleging that the company failed to provide warnings to doctors about the importance of monitoring bicarbonate levels among patients during dialysis.

What is Fresenius Granuflo and Naturalyte?

DePuy Orthopaedics and its parent, Johnson and Johnson, are facing more than 6,000 personal injury and defective metal on metal hip product claims in U.S. District Court, Northern District of Ohio. These lawsuits involve its metal on metal ASR hip replacement devices.

DePuy ASR Federal and State 2013 Trials

The first trial date in 2013 over the recalled DePuy ASR artificial metal on metal hip devices is scheduled to begin this week in Maryland state court, with a second trial expected to begin later in January in California state court. The first trial in the federal DePuy ASR hip litigation will begin on May 6, 2013 with a second trial set for July 8, 2013. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197).

As a Dallas Product Liability attorney and Bard Recovery and G2 IVC Filter lawyer, I am writing an update and as I wrote previously in my blogs, there are serious and fatal complications of the widely used Bard inferior vena cava (IVC) filters.

Our law firm on behalf of Judy Kay Alexander from Dallas, Texas have filed a defective product liability lawsuit against C.R. Bard over its G2 IVC Filter. Alexander’s lawsuit alleges that C.R. Bard was negligent, failed to warn, produced a defective design and manufacturing, breach of warranty, and negligent misrepresentation. Alexander suffered significant medical expenses, pain, suffering, loss of enjoyment of life, and disability.

The complaint was filed on December 19 in the U.S. District Court for the Northern District of Texas, Dallas Division. Alexander was implanted with a G2 filter on February 20, 2009, the IVC filter device failed and punctured her inferior vena cava vein and she also suffered damage to her right ureter.

As a Dallas, Texas medical doctor and Fresenius GranuFlo and Naturalyte recall and catastrophic injury attorney I am providing this timely update for folks who have been injured by Fresenius GranuFlo and Naturalyte dialysate solutions.

As the number of product liability lawsuits increase significantly against Fresenius Medical Care over the use of GranuFlo and Naturalyte dialysate solutions, a motion has been filed to consolidate the federal litigation for coordinated pretrial proceedings. This is known as Multi District Litigation or MDL and this consolidation is very common in complex drug and medical device lawsuit claims where there is similarity of the claims and injuries.

The consolidation motion was filed with the U.S. Judicial Panel on Multidistrict Litigation on December 12, requesting that all Naturalyte and GranuFlo lawsuits filed in U.S. District Courts to be consolidated in the District of Massachusetts as part of an MDL.

According to the FDA, patients who have artificial heart valves should not use Pradaxa. The FDA issued this latest Pradaxa warning, after data from a clinical trial showed that the blood thinner may increase the risk of strokes, heart attacks, blood clots and other catastrophic bleeding problems.

Pradaxa is not approved for patients with atrial fibrillation caused by heart valve problems. FDA is requiring a contraindication (a warning against use) of Pradaxa in patients with mechanical heart valves.

The medical study was a clinical trial known as RE-ALIGN, and it was recently cancelled in Europe to protect patient safety. The medical researchers showed that using Pradaxa with mechanical heart valves increased the risk of heart problems and had a poorer outcome than using Coumadin or warfarin.

As a Texas medical doctor and Dallas defective drug injury and wrongful death attorney, I am providing this timely update for folks who have been injured by the use of Pradaxa anticoagulant drug. According to experts, some Pradaxa patients are exposed to deadly bleeding and stroke risks because Pradaxa has no antidote to reverse its side effects and may cause bleed-out deaths.

What is the problem with Pradaxa?

According to the allegations in the plaintiff lawsuits, Pradaxa has been implicated in more than 500 U.S. deaths over a two-year period. And Boehringer now faces more than 150 lawsuits over allegations that the company sold the drug knowing the medicine could cause bleed-outs. Pradaxa stroke and hemorrhage risk increases in older patients than 75 or those with kidney problems.

As a Dallas, Texas medical doctor and Zoloft SSRI Heart and Birth Defect attorney I am providing this timely update for parents whose children have been injured by the use of these drugs during pregnancy. The first federal bellwether case to be tried over congenital birth defect side effects of the Zoloft SSRI antidepressant drug use during pregnancy is scheduled for September 2014.

What is Zoloft?

Zoloft is a Selective Serotonin Reuptake Inhibitor (SSRI) antidepressant manufactured by Pfizer. Zoloft has been associated with a number of dangerous, and deadly malformations and congenital birth defects. The most serious of these health risks involves women who become pregnant while taking Zoloft, or who are prescribed Zoloft during pregnancy. Studies have linked Zoloft use during pregnancy to serious and deadly birth defects. Zoloft (sertraline) is one of the most widely prescribed medications in the United States.

As a Dallas, Texas medical doctor and DePuy ASR metal on metal hip recall and DePuy Pinnacle metallosis and injury replacement attorney I am providing this timely update for folks who have been injured by defective metal-on-metal hip replacement implants.

The filed DePuy Pinnacle metal-on-metal hip replacement lawsuits, have now past the 3,200 mark. These lawsuits alleging defective DePuy Pinnacle hip devices and injuries in the federal court system, have been consolidated in the Northern District of Texas, Dallas division. All of the suits involve similar allegations that the DePuy Pinnacle Acetabular Cup System was defectively designed or manufactured, and that inadequate warnings were provided about the risk of early complications or problems.

What is DePuy Pinnacle Hip?

As a Nuvaring Pulmonary Embolism, Death and Deep Vein Thrombosis product liability attorney, I have written extensively about the inherent risks associated with oral contraceptive pills containing Drospirenone, like Yaz, Yasmin and Ocella and contraceptive ring like NuvaRing. The first trial for a NuvaRing blood clot lawsuit in the federal Multi-District Litigation (MDL) has been delayed until the summer of 2013.

U.S. District Judge Rodney Sippel, overseeing the consolidated Nuvaring MDL litigation, issued an order for the first NuvaRing trial date to begin on July 8, 2013. This trial date is obviously subject to change depending on the progress of the trial preparation or if a settlement is announced.

What is Nuvaring?